Lentivirus production

Mirus Bio offer solutions designed to enhance delivery of packaging and transfer vectors to adherent HEK 293T and suspension 293-F cell types to increase recombinant lentivirus production.

Both the TransIT-Lenti® and TransIT-VirusGEN® reagents are optimised to produce high functional titers making them ideal for large-scale production of viral vectors for clinical trials.